Analysed MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) News Sources
Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet
22-05-2026
yahoo.com
Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs
28-05-2026
yahoo.com
Medicenna’s MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026
03-06-2026
yahoo.com
Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms
11-06-2026
yahoo.com
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
26-06-2026
yahoo.com
Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences
14-08-2026
yahoo.com
Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
03-09-2026
yahoo.com
Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting
24-09-2026
yahoo.com
Medicenna Announces Results of Annual General and Special Meeting of Shareholders
01-10-2026
yahoo.com
What is the current price of MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS)?
The current price of MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) is $0.3021.
MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) since the previous trading day is $-0.0038.
MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) since the previous trading day is -1.2422%.
What is the most recent average sentiment score for MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS)?
The most recent average sentiment score for MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) is 77 out of 100.
What is the most recent average sentiment for MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS)?
The most recent sentiment for MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) is .
SEC-8K** Filing Available For MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.